What is Cytek Biosciences, Inc.'s return on equity?

Cytek Biosciences, Inc. (CTKB) reported return on equity of -20.9% in Q1 2026.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Cytek Biosciences, Inc. CTKB Return on equity

Return on equity at other companies

Becton, Dickinson and CompanyBDX

4.6%-1.3pp

Thermo Fisher ScientificTMO

13.5%-0.2pp

DanaherDHR

7.1%-0.1pp

Fulgent Genetics, Inc.FLGT

-6.8%+48.2pp

10x Genomics, Inc.TXG

-3%-1.4pp

TEC

Bio-TechneTECH

6.5%-3.9pp

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Calculated from Cytek Biosciences, Inc.’s reported figures.

net income/total stockholders equity=-20.9%

Based on trailing twelve months.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s return on equity?: Cytek Biosciences, Inc. (CTKB) reported return on equity of -20.9% in Q1 2026.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.